CY1120993T1 - ΠΑΡΑΓΩΓΑ CIS-ΤΕΤΡΑΫΔΡΟ-ΣΠΕΙΡΟ(ΚΥΚΛΟΕΞΑΝ-1,1'-ΠΥΡΙΔΟ[3,4-b]ΙΝΔΟΛ)-4-ΑΜΙΝΗΣ - Google Patents
ΠΑΡΑΓΩΓΑ CIS-ΤΕΤΡΑΫΔΡΟ-ΣΠΕΙΡΟ(ΚΥΚΛΟΕΞΑΝ-1,1'-ΠΥΡΙΔΟ[3,4-b]ΙΝΔΟΛ)-4-ΑΜΙΝΗΣInfo
- Publication number
- CY1120993T1 CY1120993T1 CY181101335T CY181101335T CY1120993T1 CY 1120993 T1 CY1120993 T1 CY 1120993T1 CY 181101335 T CY181101335 T CY 181101335T CY 181101335 T CY181101335 T CY 181101335T CY 1120993 T1 CY1120993 T1 CY 1120993T1
- Authority
- CY
- Cyprus
- Prior art keywords
- pain
- pyrido
- tetrahydro
- cis
- amine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Η εφεύρεση αφορά παράγωγα cis-τετραϋδρο-σπειρο(κυκλοεξαν-1,1'-πυριδο[3,4-ο]ινδολ)-4-αμίνης για τη χρήση στην αγωγή νευροπαθητικού και/ή χρόνιου πόνου, τα οποία επιδρούν στο σύστημα υποδοχέα νοσισεπτίνης/ORL-1, καθώς επίσης στο σύστημα υποδοχέα μ-οπιοειδούς και χαρακτηρίζονται ειδικότερα από μία εκλεκτική δραστικότητα κατά την αγωγή του χρόνιου πόνου (μεταξύ άλλων πόνου φλεγμονής, σπλαχνικού πόνου, πόνου όγκου, κατά προτίμηση νευροπαθητικού πόνου), χωρίς συγχρόνως να αναπτύσσουν μία έντονη δραστικότητα στον οξύ αλγαισθητικό πόνο.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10007822 | 2010-07-28 | ||
| PCT/EP2011/003771 WO2012013343A1 (de) | 2010-07-28 | 2011-07-27 | Cis-tetrahydro-spiro(cyclohexan-1,1'-pyrido[3,4-b]indol)-4-amin-derivate |
| EP11737904.0A EP2598503B1 (de) | 2010-07-28 | 2011-07-27 | Cis-tetrahydro-spiro(cyclohexan-1,1'-pyrido[3,4-b]indol)-4-amin-derivate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1120993T1 true CY1120993T1 (el) | 2019-12-11 |
Family
ID=44315152
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20141100338T CY1115186T1 (el) | 2010-07-28 | 2014-05-13 | Παραγωγα cis-τετραϋδρο-σπειρο(κυκλοεξανο-1,1'-πυριδο[3,4-b]ινδολ)-4-αμινης |
| CY181101335T CY1120993T1 (el) | 2010-07-28 | 2018-12-12 | ΠΑΡΑΓΩΓΑ CIS-ΤΕΤΡΑΫΔΡΟ-ΣΠΕΙΡΟ(ΚΥΚΛΟΕΞΑΝ-1,1'-ΠΥΡΙΔΟ[3,4-b]ΙΝΔΟΛ)-4-ΑΜΙΝΗΣ |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20141100338T CY1115186T1 (el) | 2010-07-28 | 2014-05-13 | Παραγωγα cis-τετραϋδρο-σπειρο(κυκλοεξανο-1,1'-πυριδο[3,4-b]ινδολ)-4-αμινης |
Country Status (32)
| Country | Link |
|---|---|
| US (3) | US20120029006A1 (el) |
| EP (2) | EP2598503B1 (el) |
| JP (1) | JP5898193B2 (el) |
| KR (1) | KR101927054B1 (el) |
| CN (1) | CN103025732B (el) |
| AR (1) | AR082393A1 (el) |
| AU (1) | AU2011285217B8 (el) |
| BR (1) | BR112013003642A2 (el) |
| CA (1) | CA2806633C (el) |
| CL (1) | CL2013000266A1 (el) |
| CO (1) | CO6650378A2 (el) |
| CY (2) | CY1115186T1 (el) |
| DK (2) | DK2740476T3 (el) |
| EC (1) | ECSP13012409A (el) |
| ES (2) | ES2474644T3 (el) |
| HK (1) | HK1183660A1 (el) |
| HR (2) | HRP20140569T1 (el) |
| HU (1) | HUE042732T2 (el) |
| IL (1) | IL223756A (el) |
| LT (1) | LT2740476T (el) |
| MX (1) | MX2013000751A (el) |
| NZ (1) | NZ607529A (el) |
| PE (1) | PE20130808A1 (el) |
| PL (2) | PL2740476T3 (el) |
| PT (2) | PT2740476T (el) |
| RS (2) | RS53341B (el) |
| RU (1) | RU2592283C2 (el) |
| SI (2) | SI2740476T1 (el) |
| TR (1) | TR201821273T4 (el) |
| TW (1) | TWI582092B (el) |
| WO (1) | WO2012013343A1 (el) |
| ZA (1) | ZA201301505B (el) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2970284T (pt) | 2013-03-15 | 2018-02-08 | Gruenenthal Gmbh | Cis-(e)-4-(3-fluorofenil)-2',3',4',9'-tetra-hidro-n,n-dimetil-2'-(1-oxo-3-fenil-2-propenil)-espiro[ciclo-hexano-1,1'[1h]-pirido[3,4-b]indol]-4-amina cristalina |
| US10092550B2 (en) | 2014-10-21 | 2018-10-09 | Ions Pharmaceutical S.À R.L. | Therapeutic compositions containing curcumin, harmine, and isovanillin components, and methods of use thereof |
| US9907786B2 (en) | 2014-10-21 | 2018-03-06 | Ions Pharmaceutical S.À R.L. | Therapeutic compositions containing harmine and isovanillin components, and methods of use thereof |
| EA034898B1 (ru) | 2016-01-13 | 2020-04-03 | Грюненталь Гмбх | Производные 8-амино-2-оксо-1,3-диазаспиро[4,5]декана |
| TWI640514B (zh) | 2016-01-13 | 2018-11-11 | 歌林達有限公司 | ３－（羧甲基）－８－胺基－２－側氧基－１，３－二氮－螺－［４．５］－癸烷衍生物 |
| AU2017206908B2 (en) | 2016-01-13 | 2020-07-09 | Grünenthal GmbH | 3-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives |
| MX2018008644A (es) | 2016-01-13 | 2018-11-19 | Gruenenthal Gmbh | Derivados de 3-((hetero)aril)-alquil-8-amino-2-oxo-1,3-diaza-espir o-[4.5]-decano. |
| BR112018014302B1 (pt) | 2016-01-13 | 2023-10-17 | Grünenthal GmbH | Derivados de 3-(carboxietil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano |
| PL3407888T3 (pl) | 2016-01-26 | 2021-08-30 | Intra-Cellular Therapies, Inc. | Związki pirydopirolochinoksaliny, ich kompozycje i zastosowania |
| TW201832765A (zh) * | 2017-02-24 | 2018-09-16 | 德商歌林達有限公司 | 膀胱內投藥用於治療膀胱痛之組合物 |
| TW201908295A (zh) | 2017-07-12 | 2019-03-01 | 德商歌林達有限公司 | １，３－二氮雜－螺－［３．４］－辛烷衍生物 |
| JP2019073493A (ja) * | 2017-10-17 | 2019-05-16 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | ヴルヴォディニアの治療 |
| WO2020030777A1 (en) | 2018-08-10 | 2020-02-13 | Grünenthal GmbH | Composition for treating urinary frequency and/or urinary urgency |
| MX2021011986A (es) * | 2019-04-04 | 2021-11-03 | Intra Cellular Therapies Inc | Metodos de tratamiento de dolor neuropatico. |
| MX2022007994A (es) | 2019-12-26 | 2022-09-23 | Gilgamesh Pharmaceuticals Inc | Derivados de arilciclohexilamina y su uso en el tratamiento de trastornos psiquiátricos. |
| RU2725197C1 (ru) * | 2020-02-12 | 2020-06-30 | федеральное государственное бюджетное образовательное учреждение высшего образования «Ижевская государственная медицинская академия» Министерства здравоохранения Российской Федерации | Метод оценки висцеральной гиперчувствительности |
| CA3172046A1 (en) | 2020-02-18 | 2021-08-26 | Gilgamesh Pharmaceuticals, Inc. | Specific tryptamines for use in the treatment of mood disorders |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10252667A1 (de) * | 2002-11-11 | 2004-05-27 | Grünenthal GmbH | Spirocyclische Cyclohexan-Derivate |
| DE10323172A1 (de) | 2003-05-22 | 2004-12-09 | Ina-Schaeffler Kg | Treiberstufe für ein Solenoidventil |
| DE10360792A1 (de) * | 2003-12-23 | 2005-07-28 | Grünenthal GmbH | Spirocyclische Cyclohexan-Derivate |
| DE10360793A1 (de) | 2003-12-23 | 2005-07-28 | Grünenthal GmbH | Spirocyclische Cyclohexan-Derivate |
| DE102004019502A1 (de) | 2004-04-22 | 2005-11-17 | Rheinmetall Landsysteme Gmbh | Munitionsmagazin |
| DE102004039382A1 (de) | 2004-08-13 | 2006-02-23 | Grünenthal GmbH | Spirocyclische Cyclohexan-Derivate |
| US8425881B2 (en) | 2005-03-18 | 2013-04-23 | Colgate-Palmolive Company | Antibacterial 3′,5-disubstituted 2,4′-dihydroxybiphenyl compounds, derivatives and related methods |
| DE102005016460A1 (de) * | 2005-04-11 | 2006-10-19 | Grünenthal GmbH | Spriocyclische Cyclohexanderivate zur Behandlung von Substanzabhängigkeit |
| EP1869344A2 (en) | 2005-04-12 | 2007-12-26 | The Ohio State University | All wheel drive electrically-variable transmission |
| WO2007112490A1 (en) | 2006-03-30 | 2007-10-11 | Innovative Dairy Products Pty Ltd As Trustee For The Participants Of The Cooperative Research Centre For Innovative Dairy Products | Chromosomal blocks as markers for traits |
| WO2007117173A1 (en) | 2006-04-07 | 2007-10-18 | Closed Joint Stock Company 'biocad' | Fluid dispensing system, methods and products |
| DE102006019597A1 (de) * | 2006-04-27 | 2007-10-31 | Grünenthal GmbH | Spirocyclische Cyclohexan-Derivate |
| DE102006033114A1 (de) | 2006-07-18 | 2008-01-24 | Grünenthal GmbH | Spirocyclische Azaindol-Derivate |
| DE102006046745A1 (de) * | 2006-09-29 | 2008-04-03 | Grünenthal GmbH | Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz |
| WO2008100941A2 (en) | 2007-02-12 | 2008-08-21 | Correlogic Systems Inc. | A method for calibrating an analytical instrument |
| CL2009000731A1 (es) * | 2008-03-27 | 2009-05-15 | Gruenenthal Gmbh | Compuestos derivados de ciclohexano espirociclicos sustituidos, composicion farmaceutica que contiene a dicho compuesto y su uso como moduladores del receptor de opioides µ y el receptor orl-1 para tratar el dolor, ansiedad, depresion, epilepsia, alzheimer, abuso de alcohol, hipertension, anorexia, obesidad y diarrea. |
| PT2970284T (pt) * | 2013-03-15 | 2018-02-08 | Gruenenthal Gmbh | Cis-(e)-4-(3-fluorofenil)-2',3',4',9'-tetra-hidro-n,n-dimetil-2'-(1-oxo-3-fenil-2-propenil)-espiro[ciclo-hexano-1,1'[1h]-pirido[3,4-b]indol]-4-amina cristalina |
-
2011
- 2011-06-22 TW TW100121735A patent/TWI582092B/zh not_active IP Right Cessation
- 2011-07-27 MX MX2013000751A patent/MX2013000751A/es active IP Right Grant
- 2011-07-27 PL PL14000496T patent/PL2740476T3/pl unknown
- 2011-07-27 EP EP11737904.0A patent/EP2598503B1/de active Active
- 2011-07-27 WO PCT/EP2011/003771 patent/WO2012013343A1/de active Application Filing
- 2011-07-27 RU RU2013108696/04A patent/RU2592283C2/ru active
- 2011-07-27 RS RS20140312A patent/RS53341B/en unknown
- 2011-07-27 ES ES11737904.0T patent/ES2474644T3/es active Active
- 2011-07-27 KR KR1020137004985A patent/KR101927054B1/ko active IP Right Grant
- 2011-07-27 LT LTEP14000496.1T patent/LT2740476T/lt unknown
- 2011-07-27 PT PT14000496T patent/PT2740476T/pt unknown
- 2011-07-27 BR BR112013003642A patent/BR112013003642A2/pt not_active IP Right Cessation
- 2011-07-27 CA CA2806633A patent/CA2806633C/en not_active Expired - Fee Related
- 2011-07-27 SI SI201131631T patent/SI2740476T1/sl unknown
- 2011-07-27 AR ARP110102711A patent/AR082393A1/es not_active Application Discontinuation
- 2011-07-27 PL PL11737904T patent/PL2598503T3/pl unknown
- 2011-07-27 HU HUE14000496A patent/HUE042732T2/hu unknown
- 2011-07-27 DK DK14000496.1T patent/DK2740476T3/en active
- 2011-07-27 PT PT117379040T patent/PT2598503E/pt unknown
- 2011-07-27 NZ NZ607529A patent/NZ607529A/en not_active IP Right Cessation
- 2011-07-27 JP JP2013521013A patent/JP5898193B2/ja not_active Expired - Fee Related
- 2011-07-27 DK DK11737904.0T patent/DK2598503T3/da active
- 2011-07-27 AU AU2011285217A patent/AU2011285217B8/en not_active Ceased
- 2011-07-27 CN CN201180038485.8A patent/CN103025732B/zh not_active Expired - Fee Related
- 2011-07-27 TR TR2018/21273T patent/TR201821273T4/tr unknown
- 2011-07-27 RS RS20181491A patent/RS58036B1/sr unknown
- 2011-07-27 EP EP14000496.1A patent/EP2740476B1/de active Active
- 2011-07-27 ES ES14000496T patent/ES2708930T3/es active Active
- 2011-07-27 PE PE2013000150A patent/PE20130808A1/es active IP Right Grant
- 2011-07-27 SI SI201130137T patent/SI2598503T1/sl unknown
- 2011-07-28 US US13/192,641 patent/US20120029006A1/en not_active Abandoned
-
2012
- 2012-12-20 IL IL223756A patent/IL223756A/en active IP Right Grant
-
2013
- 2013-01-28 CL CL2013000266A patent/CL2013000266A1/es unknown
- 2013-01-28 EC ECSP13012409 patent/ECSP13012409A/es unknown
- 2013-01-28 CO CO13014969A patent/CO6650378A2/es not_active Application Discontinuation
- 2013-02-27 ZA ZA2013/01505A patent/ZA201301505B/en unknown
- 2013-08-16 HK HK13109586.6A patent/HK1183660A1/xx not_active IP Right Cessation
-
2014
- 2014-05-13 CY CY20141100338T patent/CY1115186T1/el unknown
- 2014-06-17 HR HRP20140569AT patent/HRP20140569T1/hr unknown
-
2015
- 2015-09-04 US US14/846,155 patent/US20160159787A1/en not_active Abandoned
-
2017
- 2017-07-19 US US15/654,389 patent/US20170313703A1/en not_active Abandoned
-
2018
- 2018-12-10 HR HRP20182078TT patent/HRP20182078T1/hr unknown
- 2018-12-12 CY CY181101335T patent/CY1120993T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1120993T1 (el) | ΠΑΡΑΓΩΓΑ CIS-ΤΕΤΡΑΫΔΡΟ-ΣΠΕΙΡΟ(ΚΥΚΛΟΕΞΑΝ-1,1'-ΠΥΡΙΔΟ[3,4-b]ΙΝΔΟΛ)-4-ΑΜΙΝΗΣ | |
| CY1123739T1 (el) | Αντισωματα anti-cd38 | |
| CY1122624T1 (el) | Θεραπεια συνδυασμου του καρκινου | |
| CY1124632T1 (el) | Προϊοντα συζευξης αναλογων cc-1065 και διλειτουργικοι συνδετες | |
| CY1119960T1 (el) | Μεθοδοι για την αυξηση της αποτελεσματικοτητας της folr1 θεραπειας του καρκινου | |
| EA201791239A1 (ru) | ТЕТРАГИДРОПИРИДО[3,4-b]ИНДОЛОВЫЕ МОДУЛЯТОРЫ ЭСТРОГЕНОВЫХ РЕЦЕПТОРОВ И ИХ ПРИМЕНЕНИЕ | |
| CY1119283T1 (el) | Γενετικα τροποποιημενοι ποντικοι εκφραζοντες χιμαιρικα μορια μειζονος συμπλεγματος ιστοσυμβατοτητας (mhc) ii | |
| MY196474A (en) | [1,2,4]Triazolo[1,5-A]Pyridinyl Substituted Indole Compounds | |
| EA201270722A1 (ru) | Формы рифаксимина и их применение | |
| CY1120881T1 (el) | Ανταγωνιστες υποδοχεα 5-ητ3 | |
| CY1117745T1 (el) | Ετεροκυκλικες ενωσεις και χρηση αυτων ως ρυθμιστες υποδοχεα τυπου iii κινασων τυροσινης | |
| CY1116424T1 (el) | Παραγωγο αδενινης ως αναστολεας ρι3κ | |
| EA201391171A1 (ru) | Формы рифаксимина и их применение | |
| MX344737B (es) | Formas de rifaximina y sus usos. | |
| CY1124331T1 (el) | Αυξημενη βιοδιαθεσιμοτητα δραστικης ουσιας σε θεραπεια ναλτρεξονης | |
| EA201390203A1 (ru) | Способы получения тубулизинов | |
| UA111075C2 (uk) | Триазолопіридинові сполуки як інгібітори кінази рім | |
| EA201590221A1 (ru) | Способ усовершенствованного синтеза опиоидов | |
| EA201590222A1 (ru) | Способ усовершенствованного синтеза опиоидов | |
| MA34057B1 (fr) | Compositions et methodes pour le diagnostic et le traitement d'une tumeur | |
| MX2016015762A (es) | Derivados de alquilo y arilo de compuestos de 1-oxa-4,9-diazaspiro undecano que tienen actividad multimodal contra el dolor. | |
| MX347734B (es) | Anticuerpos anti-s100a4 y usos aplicaciones terapéuticas. | |
| NZ736055A (en) | Imidazopyrazines and pyrazolopyrimidines and their use as ampa receptor modulators | |
| EA201591024A1 (ru) | Димерные соединения | |
| EA201001425A1 (ru) | Азаиндольные соединения для лечения заболеваний центральной нервной системы |